ICU Medical, Inc. (ICUI)
Nasdaq: ICUI · Surgical & Medical Instruments & Apparatus · San Clemente, CA · filing with the SEC since 1995
Grade5.2
◀ Past 5.7● Present 6.2▶ Future 3.3
Who owns ICU Medical, Inc.
As filed with the SECHolders of 5% or more
4
JANUS HENDERSON GROUP Ltd. holds 11.1% of Common Stock, as its SCHEDULE 13G/A filed Aug 13, 2026 says.
Directors and officers
12
report now, of 24 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
JANUS HENDERSON GROUP Ltd.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · 10% in Aug 14, 2025
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Fuller & Thaler Asset Management, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock · 4.94% in May 13, 2026
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What ICUI reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
J Vand VI
An investee · investee · invested in, named in the 10-K filed Feb 19, 2026
64 subsidiaries in 32 countries, from the list filed with the 10-K filed Feb 19, 2026.
Insider tradesForm 4
19sales
0purchases
9sales on a scheduled plan
7people selling
$8.3Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 29 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bonnell Brian Michael | Chief Financial Officer | 5 | $2.7M | 5 | 0 | $0 |
| Woolson Daniel | VP, GM-Infusion Capital | 3 | $1.7M | 0 | 0 | $0 |
| Voigtlander Christian B. | Chief Operating Officer | 1 | $1.6M | 0 | 0 | $0 |
| Sanzone Virginia Ruth | VP, General Counsel | 6 | $1.3M | 4 | 0 | $0 |
| Sousa Ben | Chief Information Officer | 1 | $400,000 | 0 | 0 | $0 |
| Greenberg David C. | director | 1 | $300,000 | 0 | 0 | $0 |
| Finney Elisha W | director | 2 | $200,000 | 0 | 0 | $0 |